Gene disruption of caspase-3 prevents MPTP-induced Parkinson’s disease in mice
Authors:
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 402 (2) , 312-318
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivoNeurobiology of Disease, 2004
- Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammationCell and tissue research, 2004
- Caspase-11 Mediates Inflammatory Dopaminergic Cell Death in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's DiseaseJournal of Neuroscience, 2004
- Caspase-Dependent and -Independent Cell Death Pathways in Primary Cultures of Mesencephalic Dopaminergic Neurons after Neurotoxin TreatmentJournal of Neuroscience, 2003
- Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's DiseaseJournal of Neuroscience, 2000
- Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's DiseaseExperimental Neurology, 2000
- Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's diseaseProceedings of the National Academy of Sciences, 2000
- Cell death mechanisms in Parkinson's diseaseJournal of Neural Transmission, 2000
- Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson diseaseNature Medicine, 1999
- Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of miceNeuroscience Letters, 1996